Zhongling Zhu

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells.

Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells.

Journal: Lipids in health and disease

Published: June 29, 2023

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways.

Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways.

Journal: Frontiers in pharmacology

Published: May 20, 2021

DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: May 15, 2018

Apoptosis induction in K562 human myelogenous leukaemia cells is connected to the modulation of Wnt/β-catenin signalling by BHX, a novel pyrazoline derivative.

Apoptosis induction in K562 human myelogenous leukaemia cells is connected to the modulation of Wnt/β-catenin signalling by BHX, a novel pyrazoline derivative.

Journal: Cell proliferation

Published: September 19, 2017

BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling.

BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling.

Journal: Scientific reports

Published: March 27, 2017

Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.

Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.

Journal: Journal of neurochemistry

Published: March 12, 2017

BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus.

BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus.

Journal: Scientific reports

Published: September 07, 2016

Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.

Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.

Journal: American journal of translational research

Published: April 28, 2016

Regulation of cell transformation by Rb-controlled redox homeostasis.

Regulation of cell transformation by Rb-controlled redox homeostasis.

Journal: PloS one

Published: January 08, 2014

Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway.

Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway.

Journal: Molecular cancer

Published: May 22, 2013

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors.

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors.

Journal: International journal of nanomedicine

Published: January 16, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026